Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors.
D001679:Biogenic Amines / Q000096:biosynthesis*; D002395:Catecholamines / Q000096:biosynthesis; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D012701:Serotonin / Q000096:biosynthesis; D014364:Tryptophan / Q000627:therapeutic use; D014443:Tyrosine / Q000627:therapeutic use
D001679:Biogenic Amines; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D014443:Tyrosine; D007980:Levodopa; D014364:Tryptophan